metadata toggle
Loading image navigation...
No image index could be found for this publication.
Close this Panel
Qualitative and quantitative composition
Each dose (0.2 ml for subcutaneous or 0.05 ml for in ovo) of the vaccine suspension contains:
Active substances:
Marek’s disease (MD) virus, serotype 1, strain RN1250 (cell-associated), live:
2.9 to 3.9 log10 PFU*
Turkey herpesvirus (HVT), strain vHVT013-69 (cell-associated), expressing the VP2 protein gene of infectious bursal disease (IBD), strain Faragher 52/70 virus, live:
3.6 to 4.4 log10 PFU*
*PFU: plaque forming units.
Excipients:
Qualitative composition of excipients and other constituents
Vaccine concentrate:
Dimethyl sulfoxide
199 Earle medium
Sodium hydrogen carbonate
Hydrochloric acid
Water for injections
Solvent:
Sucrose
Casein hydrolysate
Phenolsulfonphthalein (Phenol red)
Dipotassium phosphate
Potassium dihydrogen phosphate
Sodium hydroxide or hydrochloric acid
Water for injections